Loading the company…
Loading the company…
In 2025, Hollister reported engagement with 400 surgeons and other clinicians in the states MedaRep covers, worth $25K in consulting, speaking, meals and travel for its device products, the most in New Jersey ($2,562 to 33). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New Jersey ($2,562, 33 engaged), New York ($2,081, 29 engaged), Texas ($1,707, 28 engaged), Florida ($1,455, 32 engaged), New Mexico ($1,224, 9 engaged).
In the last ten years FDA made 0 decisions for Hollister (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family. The latest was on 1999-10-14.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 8 |
| HOLLISTER HYDROCOLLOID WOUND DRESSINGS |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Hollister.